Back

Economic evaluation of alternative anticoagulants for the stroke prevention in the patients with atrial fibrillation

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 5 - Registries and cost of treatment Antiarrhythmic drugs ESC Premium Access ESC Congress 2017

About the speaker

Photo
Miss Mei Chuan Lee

Chi-Mei Medical Center, Tainan (Taiwan)

11 More presentations in this session

Presentation thumbnail
Global healthcare resource use in 39,670 patients with AF: perspectives from GARFIELD-AF
Mr P. Cozzolino (Monza, IT)
Abstract Slides
Presentation thumbnail
Cost-effectiveness analysis of a handheld ECG machine used for a population-wide screening programme: the Belgian Heart Rhythm Week Screening programme
Associate Professor M. Proietti (Milan, IT)
Abstract Slides
Presentation thumbnail
Health-related quality of life change after thoracoscopic surgery for advanced atrial fibrillation: results of the AFACT study
Doctor W. Berger (Nieuwegein, NL)
Abstract
Presentation thumbnail
Incident atrial fibrillation and the risk of stroke in patients with chronic kidney disease
Doctor K. Szummer (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Atrial arrhythmia detection by Implantable Loop Recorder in patients with and without previous stroke; impact of arrhythmia duration and time to diagnosis
Doctor P. Chousou (Cambridge, GB)
Abstract Slides

Access the full session

Session thumbnail
Poster session 5 - Registries and cost of treatment

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources